Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones

Fibroblast growth factor 21 is an emerging metabolic regulator that was recently proposed to be a fed-state inducible factor in adipose tissue. As mice lacking FGF21 were refractory to treatment with rosiglitazone, FGF21 was suggested to underlie PPARγ-driven pharmacology and side effect profile (Du...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Adams, Andrew C., Coskun, Tamer, Cheng, Christine C., O′Farrell, Libbey S., DuBois, Susan L., Kharitonenkov, Alexei
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2013
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3773835/
https://ncbi.nlm.nih.gov/pubmed/24049735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2013.05.005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares